From Procedural to Risk-Based Compliance and Enforcement

Download Now


In this presentation, ARC analyst John Blanchard outlines the steps required for moving from the old to the new model, and what they mean for pharmaceutical manufacturers and the FDA.

Login or register below to access this 14-page, 294 KB presentation.